Form 38.5(b) - Willis Towers Watson plc- Amendment

Source: RNS
RNS Number : 9104C
Goldman Sachs & Co. LLC
23 June 2021
 

Amendment - due to the amendment of Equity and Derivative transactions, the disclosure made on 22 June for dealings on 21 June has been updated. Sections 2(a), 3(a) and 3(b) have been updated.

 

FORM 38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

1. KEY INFORMATION

 

Name of exempt principal trader

GOLDMAN SACHS & CO. LLC

Company dealt in

WILLIS TOWERS WATSON PLC

Class of relevant security to which the dealings being disclosed relate (Note1)

USD 0.000304635 ordinary shares

Date of dealing

21 June 2021

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in  (Note 2)

 

 

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

2,588,489.542

(2.00)

2,494,728.5420

(1.93)

(2) Derivatives (other than options)

663,341

(0.51)

2,783,458

(2.15)

(3) Options and agreements to purchase/sell

0

(0.00)

0

(0.00)

Total

3,251,830.542

(2.52)

5,278,186.542

(4.09)

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in  (Note 2)

 

Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

 

 

 

 

(2) Derivatives (other than options)

 

 

 

 

(3) Options and agreements to purchase/sell

 

 

 

 

Total

 

 

 

 

 

3.    DEALINGS (Note 3)

(a) Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit  (Note 4)

Purchase

100

225.6000 USD

Purchase

66

229.0200 USD

Purchase

34

229.0200 USD

Purchase

4

229.1200 USD

Purchase

91

229.1200 USD

Purchase

5

229.1200 USD

Purchase

10

229.2600 USD

Purchase

90

229.2800 USD

Purchase

10

229.2800 USD

Purchase

100

229.2900 USD

Purchase

100

229.5900 USD

Purchase

100

229.7100 USD

Purchase

100

230.0200 USD

Purchase

100

230.0400 USD

Purchase

93

230.0700 USD

Purchase

7

230.0850 USD

Purchase

12

230.1800 USD

Purchase

1

230.1800 USD

Purchase

3,815

230.1800 USD

Purchase

189

230.1800 USD

Purchase

6

230.2500 USD

Purchase

100

230.4200 USD

Sale

27

226.5100 USD

Sale

20

226.5200 USD

Sale

100

226.8900 USD

Sale

28

227.2100 USD

Sale

4

227.3000 USD

Sale

3

227.3000 USD

Sale

34

227.3000 USD

Sale

35

227.3000 USD

Sale

1

227.3000 USD

Sale

100

227.3000 USD

Sale

100

229.8600 USD

Sale

100

229.8800 USD

Sale

100

229.9200 USD

Sale

100

229.9200 USD

Sale

100

229.9200 USD

Sale

100

230.0000 USD

Sale

100

230.0000 USD

Sale

100

230.0100 USD

Sale

20

230.0300 USD

Sale

80

230.0300 USD

Sale

100

230.0400 USD

Sale

100

230.0700 USD

Sale

50

230.0800 USD

Sale

50

230.0800 USD

Sale

100

230.0800 USD

Sale

100

230.0800 USD

Sale

100

230.0900 USD

Sale

80

230.0900 USD

Sale

100

230.1000 USD

Sale

100

230.1000 USD

Sale

100

230.1000 USD

Sale

20

230.1000 USD

Sale

50

230.1000 USD

Sale

100

230.1000 USD

Sale

23

230.1100 USD

Sale

100

230.1100 USD

Sale

80

230.1100 USD

Sale

100

230.1100 USD

Sale

8

230.1100 USD

Sale

100

230.1100 USD

Sale

100

230.1100 USD

Sale

100

230.1100 USD

Sale

40

230.1100 USD

Sale

20

230.1200 USD

Sale

100

230.1200 USD

Sale

10

230.1200 USD

Sale

100

230.1200 USD

Sale

100

230.1200 USD

Sale

10

230.1200 USD

Sale

20

230.1200 USD

Sale

125

230.1200 USD

Sale

20

230.1300 USD

Sale

40

230.1300 USD

Sale

100

230.1300 USD

Sale

100

230.1300 USD

Sale

100

230.1300 USD

Sale

100

230.1300 USD

Sale

100

230.1300 USD

Sale

7

230.1500 USD

Sale

7

230.1600 USD

Sale

92

230.1600 USD

Sale

100

230.1700 USD

Sale

93

230.1700 USD

Sale

93

230.1700 USD

Sale

100

230.1700 USD

Sale

163

230.1800 USD

Sale

15,000

230.1800 USD

Sale

109

230.1800 USD

Sale

100

230.1800 USD

Sale

1

230.1800 USD

Sale

45

230.1800 USD

Sale

245

230.1800 USD

Sale

100

230.1900 USD

Sale

100

230.1900 USD

Sale

100

230.2000 USD

Purchase (Borrow New)

37,200

N/A

Sale (Borrow Full Return)

3,244

N/A

Purchase (Borrow New)

3,244

N/A

Sale (Loan Adjust)

2,678

N/A

Sale (Loan Adjust)

227

N/A

Sale (Loan Adjust)

920

N/A

Sale (Loan Adjust)

5,847

N/A

Purchase (Loan Partial Return)

227

N/A

Purchase (Loan Partial Return)

920

N/A

Sale (Borrow Full Return)

14,100

N/A

Sale (Borrow Partial Return)

10,200

N/A

Sale (Borrow Full Return)

800

N/A

Purchase (Loan Full Return)

683

N/A

Sale (Borrow Full Return)

14,100

N/A

Sale (Borrow Partial Return)

14,800

N/A

Purchase (Borrow New)

6,382

N/A

Sale (Borrow Full Return)

6,382

N/A

Purchase (Borrow New)

9,626

N/A

Sale (Borrow Partial Return)

1,000

N/A

Sale (Borrow Partial Return)

2,000

N/A

Sale (Borrow Partial Return)

3,000

N/A

Sale (Borrow Partial Return)

4,000

N/A

Sale (Borrow Full Return)

9,500

N/A

Sale (Borrow Full Return)

6,382

N/A

Purchase (Borrow New)

6,382

N/A

Sale (Borrow Partial Return)

16,385

N/A

Sale (Borrow Full Return)

3,244

N/A

Purchase (Borrow New)

19,629

N/A

 

(b) Derivatives transactions (other than options transactions)

 

Product name, e.g. CFD

Nature of transaction  (Note 5)

Number of relevant securities  (Note 6)

Price per unit  (Note 4)

CFD

Reducing a long position

806

229.3494 USD

CFD

Reducing a short position

1,000

229.9580 USD

 

(c) Options transactions in respect of existing relevant securities

 

(i) Writing, selling, purchasing or varying

 

Product name,e.g. call option

Writing, selling,  purchasing, varying etc.

Number of securities to which the option relates  (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit  (Note 4)

 

 

 

 

 

 

 

 

(ii)            Exercising

 

Product name,e.g. call option

Number of securities

Exercise price per unit  (Note 4)

 

 

 

 

(d)            Other dealings (including transactions in respect of new securities)  (Note 3)

 

Nature of transaction  (Note 7)

Details

Price per unit (if applicable)  (Note 4)

 

 

 

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.  If none, this should be stated. 

NONE

 

Is a Supplemental Form 8 attached? (Note 9)        YES

 

Date of disclosure

23 June 2021

Contact name

Paul Grainger and Kashif Rafiq

Telephone number

+44(20) 7552 9835 / +44(20) 7051 0547

Name of offeree/offeror with which connected

WILLIS TOWERS WATSON PLC

Nature of connection (Note 9)

Advisor to Offeree

 

SUPPLEMENTAL FORM 38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DETAILS OF OPEN POSITIONS

 

OPEN POSITIONS (Note 1)

 

Product name,e.g. call option

Written or purchased

Number of relevant securities to which the option or derivative relates

Exercise price (Note 2)

Type, e.g. American, European etc.

Expiry date

Swap

Sold

185

0.0000

N/A

23/09/2021

Swap

Sold

562

0.0000

N/A

29/06/2021

Swap

Sold

38,107

0.0000

N/A

16/05/2022

Swap

Sold

58,295

0.0000

N/A

18/07/2022

Swap

Sold

84,311

0.0000

N/A

16/05/2022

Swap

Sold

140,000

0.0000

N/A

25/03/2022

Swap

Sold

140,000

0.0000

N/A

24/03/2022

Swap

Purchased

597,000

0.0000

N/A

04/01/2023

Swap

Sold

597,000

0.0000

N/A

04/01/2023

 

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rules 8 and 38.5 of the Rules. If in doubt, consult the Panel.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEEAKKDALSFEFA